Sol Atriyal Apendiks Kapatılmasına Bağlı Periprosedürel İnme

Reddy, V.Y., Doshi, S.K., Sievert, H., Buchbinder, M., Neuzil, P., Huber, K., Holmes, D.R. (2013). Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial. *Circulation*, 127(6), 720-729.

Holmes, D.R., Kar, S., Price, M.J., Whisenant, B., Sievert, H., Doshi, S.K., ... & Reddy, V.Y. (2014). Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure Device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. *Journal of the American College of Cardiology*, 64(1), 1-12.

Garot P., Cormier B., Horvilleur J. Device-related thrombus after left atrial appendage closure. Interv Cardiol. 2019;14(1):42–44.

Alkhouli M., Busu T., Shah K., Osman M., Alqahtani F., Raybuck B. Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis. J Am Coll Cardiol EP. 2018;4(12):1629–1637.

Vukomanovic D., Unzek S., Malik K., et al. Massive device-related thrombus after LAA occlusion: intraoperative insights into mechanism. J Am Coll Cardiol Case Rep. 2022;4(21):1409–1413. [PMC free article]

Seo J.W., Kim D.Y., Yun N., Kim D.M. Coronavirus disease 2019-associated coagulopathy. Microorganisms. 2022;10(8):1556.

Ortega-Paz L., Capodanno D., Montalescot G., Angiolillo D.J. Coronavirus disease 2019-associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management. J Am Heart Assoc. 2021;10(3)

Shekar K., Badulak J., Peek G., et al. Extracorporeal life support organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers. ASAIO J. 2020;66(7):707–721.

Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005;150:288–93.

Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al. 4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation. J Am Coll Cardiol 2022;79:1–14

Perrotta L, Bordignon S, Dugo D, Fürnkranz A, Konstantinou A, Ricciardi G et al (2014) Complications from left atrial appendage exclusion devices. J Atr Fibrillation 7:66–72

Boersma LV, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E et al (2016) Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J 37:2465–2474

Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG et al (2007) Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 49:1490–1495

Çöteli , C., Aygün, S., Ateş, A. H., Karakulak , U. N., Yorgun, H., Şahiner, L., Kaya, B., & Aytemir, K. (2022). Effective Therapeutic Intervention for Left Atrial Appendage Thrombus: Percutaneous Left Atrial Appendage Closure. European Journal of Therapeutics, 28(3), 171–175.

Tarantini G, D'Amico G, Latib A, Montorfano M, Mazzone P, Fassini G, Maltagliati A, Ronco F, Saccà S, Cruz-Gonzalez I, Ibrahim R, Freixa X. Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and left appendage thrombus: feasibility, safety and clinical efficacy. EuroIntervention. 2018 Jan 20;13(13):1595-1602. doi: 10.4244/EIJ-D-17-00777. PMID: 29086706.

Wang Z, Wang K, Lu S, et al. Surgical and percutaneous left atrial appendage intervention: silent cerebral embolism considerations. Eur J Cardiothorac Surg. 2023;63:63